JY
TLSA icon

Jeff Yass’s Tiziana Life Sciences TLSA Stock Holding History

Jeff Yass’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,200
Closed -$42K – 13263
2021
Q1 		$42K Sell
15,200
-200
-1% -$664 ﹤0.01% 12069
2020
Q4 		$31K Buy
+15,400
New +$48.7K ﹤0.01% 10841

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
MAWAG
Mid-American Wealth Advisory Group Kansas City, Missouri $277M AUM 6.22% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jeff Yass's TLSA Position: Q2 2026 in Review

Jeff Yass sold out of Tiziana Life Sciences (TLSA) in Q2 2026, closing a stake of 17,267 shares — an estimated $22.4K sold.

Jeff Yass first reported a position in TLSA in Q4 2020 and held it in 12 quarters. The position peaked at $136K in Q2 2025. 31 funds tracked by Wall St. Rank hold TLSA as of Q2 2026.

  • Jeff Yass reported no remaining Tiziana Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 17,267 Tiziana Life Sciences shares in Q2 2026, an estimated $22.4K.
  • Jeff Yass first reported a position in Tiziana Life Sciences in Q4 2020 and held it in 12 quarters.
  • Jeff Yass's Tiziana Life Sciences position peaked at $136K in Q2 2025.
  • 31 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.